Intravenous immunoglobulin - New indications and mechanisms of action

被引：4
|
作者：
Shoenfeld, Y [1 ]
Gershwin, ME
机构：
[1] Chaim Sheba Med Ctr, Dept Internal Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Res Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Laura Schwarz Kipp Chair Res Autoimmun Dis, IL-69978 Tel Aviv, Israel
[5] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
来源：
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 2005年 / 29卷 / 03期
关键词：
Thrombocytopenia; Purpura; Clinical Review; Intravenous Immunoglobulin; Immunology Volume;
D O I：
10.1385/CRIAI:29:3:165
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：165 / 166
页数：2
相关论文
共 50 条
  • [31] Mechanisms of action of intravenous immunoglobulin: Clinical implications in autoimmune and inflammatory diseases
    Ballow, M
    [J]. INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 123 - 127
  • [32] Intravenous immunoglobulin - Indications and mechanisms in cardiovascular diseases (vol 7, pg 445, 2008)
    Udi, Nussinovitch
    Shoenfeld, Yehuda
    [J]. AUTOIMMUNITY REVIEWS, 2010, 9 (04) : 246 - 246
  • [33] Mechanism of action of intravenous immunoglobulin
    Corbetta, G
    Spath, P
    Dominioni, L
    [J]. INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 343 - 344
  • [34] Immunomodulatory action of intravenous immunoglobulin
    Sewell, WAC
    Jolles, S
    [J]. IMMUNOLOGY, 2002, 107 (04) : 387 - 393
  • [35] Intravenous human immunoglobulin indications in pregnancy loss
    Cavalcanti, M
    [J]. PLACENTA, 2006, 27 (01) : A27 - A27
  • [36] Indications and safety of intravenous and subcutaneous immunoglobulin therapy
    Rezaei, Nima
    Abolhassani, Hassan
    Aghamohammadi, Asghar
    Ochs, Hans D.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 301 - 316
  • [37] A NEW ACTION MECHANISM OF INTRAVENOUS IMMUNOGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA
    HONDA, J
    NATORI, H
    OIZUMI, K
    YOKOYAMA, M
    [J]. VOX SANGUINIS, 1993, 64 (03) : 186 - 187
  • [38] Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
    Jagadeesh Bayry
    Sébastien Lacroix-Desmazes
    Michel D Kazatchkine
    Srini V Kaveri
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 262 - 272
  • [39] Intravenous immunoglobulin-indications and mechanisms in cardiovascular diseases (vol 7, pg 445, 2008)
    Nussinovitch, Udi
    Shoenfeld, Yehuda
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (03) : 180 - 180
  • [40] Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
    Bayry, Jagadeesh
    Lacroix-Desmazes, Sebastien
    Kazatchkine, Michel D.
    Kaveri, Srini V.
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (05): : 262 - 272
12345